{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-26-006777","form_type":"8-K","ticker":"SBFM","cik":"0001402328","company_name":"Sunshine Biopharma Inc.","filed_at":"2026-08-28T20:05:23+00:00","discovered_at":"2026-08-28T20:08:03.231135+00:00","generated_at":"2026-08-28T20:08:52.664118+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Sunshine Biopharma director Dr. Andrew Keller will not seek reelection","bullets":["Dr. Andrew Keller notified company on Aug 25, 2026 he will not seek reelection.","His term expires at the next annual shareholder meeting; no replacement named.","Board composition will change after his departure."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-26-006777","json":"https://secwatch.observer/filing/0001683168-26-006777.json","markdown":"https://secwatch.observer/filing/0001683168-26-006777.md","text":"https://secwatch.observer/filing/0001683168-26-006777.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1402328/000168316826006777/0001683168-26-006777-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1402328/000168316826006777/sunshine_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-28T20:08:52.664118+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}